鼠李糖乳杆菌
益生菌
促炎细胞因子
免疫学
移植物抗宿主病
生物
移植
脂多糖
调理疗法
乳酸菌
微生物学
医学
细菌
炎症
造血干细胞移植
内科学
遗传学
作者
Armin Gerbitz,Michael Schultz,Andrea Wilke,Hans‐Jörg Linde,Jürgen Schölmerich,Reinhard Andreesen,Ernst Holler
出处
期刊:Blood
[American Society of Hematology]
日期:2004-02-17
卷期号:103 (11): 4365-4367
被引量:179
标识
DOI:10.1182/blood-2003-11-3769
摘要
Abstract Acute graft-versus-host disease (aGVHD) often limits feasibility and outcome of allogeneic bone marrow transplantation. Current pathophysiologic concepts of aGVHD involve conditioning regimens, donor-derived T cells, proinflammatory cytokines, and bacterial lipopolysaccharide (LPS) as a major trigger for aGVHD. LPS derives mostly from gram-negative bacteria and can enter circulation through the impaired mucosal barrier after the conditioning regimen. Probiotic microorganisms have been shown to alter the composition of the intestinal microflora and thereby mediate anti-inflammatory effects. We hypothesized that modifying the enteric flora using the probiotic microorganism Lactobacillus rhamnosus GG, would ameliorate aGVHD. Here we show that oral administration of Lactobacillus rhamnosus GG before and after transplantation results in improved survival and reduced aGVHD. Furthermore, subculturing of mesenteric lymph node tissue revealed a reduced translocation of enteric bacteria. Our findings suggest that alteration of the intestinal microflora plays an important role in the initiation of experimental aGVHD. (Blood. 2004;103:4365-4367)
科研通智能强力驱动
Strongly Powered by AbleSci AI